A Japan-based pharmaceutical manufacturer focused on anti-infectives, central nervous system treatments, and other specialty medicines, with a long history in antibiotic development. The company collaborates with global partners on HIV therapies and has expanded into antiviral drugs and vaccine-rela...
4 members of Congress have disclosed 13 trades in Shionogi & Co., Ltd. (SGIOY), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-07-19 | Josh Gottheimer | buy | $1K – $15K |
| 2024-06-18 | Josh Gottheimer | sell | $1K – $15K |
| 2023-10-16 | Josh Gottheimer | buy | $1K – $15K |
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | buy | $1K – $15K |
| 2023-02-27 | Daniel Goldman | sell | $1K – $15K |
| 2021-04-14 | Josh Gottheimer | buy | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $1K – $15K |
| 2020-08-04 | Greg Gianforte | buy | $15K – $50K |
| 2020-02-20 | Greg Gianforte | buy | $100K – $250K |
| 2020-02-18 | Josh Gottheimer | buy | $1K – $15K |
| 2020-02-14 | Josh Gottheimer | buy | $1K – $15K |